https://www.youtube.com/watch?v=mihvcRY53Ys Dr.
Post# of 151654

Dr. Yo Samantha Mottet video for anyone who didn't see it.
Can Cytodyn and its investors agree with Dr. Yo and Ms. Mottet that Leronlimab belongs in the FDA toolbox? This is a reasonable goal and well-warranted anecdotally. When the CD-12 results are in, Leronlimab may earn its way permanently into the toolbox. For now patients and their families deserved the opportunity to request it and have it administered. Why do they have to die?

